8-K 1 d918032-2.txt 07/31/2003 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 -------------- FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2003 MEDSOURCE TECHNOLOGIES, INC. -------------------------------------------------------------------------------- (Exact Name of Registrant as Specified in Charter) Delaware 000-49702 52-2094496 -------- --------- ---------- (State or Other Jurisdiction (Commission File No.) (IRS Employer of Incorporation) Identification No.) 110 Cheshire Lane, Suite 100, Minneapolis, MN 55305 --------------------------------------------- ----- (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code (952) 807-1234 Item 7. Financial Statements, Pro Forma Financial Financial Information. --------------------------------------------------------------- (a) Financial Statements of Business Acquired: Not applicable (b) Pro Forma Financial Information: Not applicable (c) Exhibits. 99.1 MedSource Technologies, Inc. Press Release dated July 31, 2003 Item 9. Regulation FD Disclosure. ------------------------ This information, furnished under "Item 9. Regulation FD Disclosure," is intended to be furnished under "Item 12. Results of Operations and Financial Condition" in accordance with Securities and Exchange Commission Release No. 33-8216. The information in this Current Report Form 8-K, including the Exhibit attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as expressly set forth by specific reference in such filing. On July 31, 2003, MedSource Technologies, Inc. issued a press release announcing its results of operations for its fiscal fourth quarter and year ended June 30, 2003. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: July 31, 2003 MEDSOURCE TECHNOLOGIES, INC. By: /s/ William J. Kullback ------------------------------------- William J. Kullback Senior Vice President - Finance and Chief Financial Officer EXHIBIT INDEX ------------- Exhibit No. Description ----------- ----------- 99.1 MedSource Technologies, Inc. Press Release dated July 31, 2003